These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14681702)

  • 1. Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector.
    Lee JT; Yu SS; Han E; Kim S; Kim S
    Gene Ther; 2004 Jan; 11(1):94-9. PubMed ID: 14681702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS; Kim JM; Kim S
    Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
    Pambalk K; Hohenadl C; Salmons B; Günzburg WH; Renner M
    Biochem Biophys Res Commun; 2002 Apr; 293(1):239-46. PubMed ID: 12054590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of retroviral vectors with enhanced efficiency of transgene expression.
    Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
    J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of splicing efficiency by the mouse histone H2a element in a murine leukemia virus-based retroviral vector.
    Lee JT; Yu SS; Kim VN; Kim S
    Mol Ther; 2007 Jan; 15(1):167-72. PubMed ID: 17164788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer.
    Cmejlova J; Hildinger M; Cmejla R; Fuchs O; Kalabova D; Baum C; Jelinek J
    Gene Ther; 2003 Jun; 10(12):1061-5. PubMed ID: 12776165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells.
    Krall WJ; Skelton DC; Yu XJ; Riviere I; Lehn P; Mulligan RC; Kohn DB
    Gene Ther; 1996 Jan; 3(1):37-48. PubMed ID: 8929910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.
    Jang J; Lee JT; Lee K; Kim S; Kim JY; Yoon K; Kim S
    Gene Ther; 2011 Mar; 18(3):240-9. PubMed ID: 20944681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors.
    Zhao Y; Low W; Collins MK
    Gene Ther; 2000 Feb; 7(4):300-5. PubMed ID: 10694810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
    Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
    J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
    Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
    Gene; 2006 May; 372():153-61. PubMed ID: 16488559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
    Hettich E; Janz A; Zeidler R; Pich D; Hellebrand E; Weissflog B; Moosmann A; Hammerschmidt W
    Gene Ther; 2006 May; 13(10):844-56. PubMed ID: 16421600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
    Higashimoto T; Urbinati F; Perumbeti A; Jiang G; Zarzuela A; Chang LJ; Kohn DB; Malik P
    Gene Ther; 2007 Sep; 14(17):1298-304. PubMed ID: 17597793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient gene expression mediated by integrase-defective retroviral vectors.
    Yu SS; Dan K; Chono H; Chatani E; Mineno J; Kato I
    Biochem Biophys Res Commun; 2008 Apr; 368(4):942-7. PubMed ID: 18279658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General principles of retrovirus vector design.
    Chang T; Yee JK
    Methods Enzymol; 2012; 507():1-14. PubMed ID: 22365766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.